These data indicate that MBD3 binds preferentially to unmethylated CpG islands in human breast cancer cells and agrees with recent biochemical studies indicating that MBD3 has no measurable biochemical preference for methylated cytosine [21], [22]. The gene discussed is MBD3; the disease is breast cancer.